{"id":58731,"date":"2024-01-17T16:06:41","date_gmt":"2024-01-17T15:06:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/"},"modified":"2024-01-17T16:06:41","modified_gmt":"2024-01-17T15:06:41","slug":"attune-medical-announces-support-of-af-symposium-2024","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/","title":{"rendered":"Attune Medical\u00ae Announces Support of AF Symposium 2024"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Company\u2019s ensoETM<sup>\u00ae<\/sup> holds FDA marketing authorization for reducing the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.<\/i><\/p>\n<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;Attune Medical<sup>\u00ae<\/sup>, a pioneer in the field of esophageal temperature management with its ensoETM<sup>\u00ae<\/sup> device, is providing significant support for the upcoming AF Symposium as part of the company\u2019s corporate mission. AF Symposium, scheduled for February 1-3 in Boston, Massachusetts, gathers the world&#8217;s leading electrophysiologists to share, in a highly interactive environment, the latest advances in the treatment of atrial fibrillation.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/5\/EnsoETM_inserted_illustration.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/21\/EnsoETM_inserted_illustration.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/5\/EnsoETM_inserted_illustration.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/22\/EnsoETM_inserted_illustration.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000273\/5\/AttuneMedical-Horizontal-Primary.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000273\/21\/AttuneMedical-Horizontal-Primary.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000273\/5\/AttuneMedical-Horizontal-Primary.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000273\/22\/AttuneMedical-Horizontal-Primary.jpg\"><\/a><\/p>\n<p>\nAs part of its mission to support education and enhance patient outcomes, Attune Medical is the primary corporate sponsor of the AF Symposium EP Fellows\u2019 Scholarship Program and the dedicated Interactive Educational Program for fellows on Saturday, February 3 from 4-8 p.m. The AF Symposium Fellows\u2019 Program offers a unique opportunity to engage with leaders in Cardiac Electrophysiology during this exclusive four-hour session.<\/p>\n<p>\nA highlight of the Symposium, with the company&#8217;s proactive esophageal cooling as a focal point, will be Spotlight Session 1 (New and Emerging Technologies in Arrhythmia Management) on Thursday, February 1 at 8:30 a.m. At this session, Dr. Dinesh Sharma will present \u201c<i>Proactive Esophageal Cooling \u2013 Data Update and Overview<\/i>,\u201d focusing on the benefits of esophageal cooling beyond <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.jacc.org%2Fdoi%2F10.1016%2Fj.jacep.2023.08.022&amp;esheet=53883252&amp;newsitemid=20240117068352&amp;lan=en-US&amp;anchor=safety&amp;index=1&amp;md5=ab92cc322901a6084d4615484a9d4950\" rel=\"nofollow noopener\" shape=\"rect\">safety<\/a> alone, including <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs10840-022-01204-1&amp;esheet=53883252&amp;newsitemid=20240117068352&amp;lan=en-US&amp;anchor=shorter+procedure+times&amp;index=2&amp;md5=a0401f258e75125f3078ba596483b8ef\" rel=\"nofollow noopener\" shape=\"rect\">shorter procedure times<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8519316%2F&amp;esheet=53883252&amp;newsitemid=20240117068352&amp;lan=en-US&amp;anchor=reduced+fluoroscopy+requirements&amp;index=3&amp;md5=970824e46f0c5c187f4e91c1aa18ca17\" rel=\"nofollow noopener\" shape=\"rect\">reduced fluoroscopy requirements<\/a>, greater <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Ffull%2F10.1080%2F13696998.2022.2160596&amp;esheet=53883252&amp;newsitemid=20240117068352&amp;lan=en-US&amp;anchor=hospital+savings&amp;index=4&amp;md5=df8b23edcacc426d92a5af3b1149667a\" rel=\"nofollow noopener\" shape=\"rect\">hospital savings<\/a>, and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs10840-023-01474-3&amp;esheet=53883252&amp;newsitemid=20240117068352&amp;lan=en-US&amp;anchor=improved+long-term+freedom+from+arrhythmia&amp;index=5&amp;md5=a94a390b059c35c38c910f65defdeb5a\" rel=\"nofollow noopener\" shape=\"rect\">improved long-term freedom from arrhythmia<\/a>.<\/p>\n<p>\nIn addition, proactive esophageal cooling will be discussed in several poster presentations including:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nMulti-Site Analysis of the Impact on Throughput Associated with Proactive Esophageal Cooling;<\/li>\n<li>\nCost Analysis of Left Atrial Ablation Procedures Using Active Esophageal Cooling &#8211; Influence of Procedure Time;<\/li>\n<li>\nLow Continuity Index Using Active Esophageal Cooling During Radiofrequency Ablation;<\/li>\n<li>\nAcute and Long-Term Procedural Effects with Proactive Esophageal Cooling During Radiofrequency Ablation;<\/li>\n<li>\nReduction of Atrioesophageal Fistula Rates After Adoption of Proactive Esophageal Cooling During Atrial Fibrillation Ablation &#8211; Further Statistical Analysis.<\/li>\n<\/ul>\n<p>\nThe company will also feature prominently on the conference show floor at booth 217, providing an opportunity for hands-on interaction with the ensoETM.<\/p>\n<p>\nAttune received <i>De Novo<\/i> marketing authorization from the US FDA for use of its ensoETM to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures in September 2023, and has distributed over 60,000 devices to more than 200 hospitals and electrophysiology labs.<\/p>\n<p>\nDr. Sharma, Section Head of Electrophysiology for the Rooney Heart Institute and the Fritz and Kathy Friday Endowed Chair of Electrophysiology at NCH Healthcare System in Naples, Florida, commented, \u201cI\u2019ve been using proactive esophageal cooling for a year now, and appreciate the patient safety benefits, as well as the additional improvements it offers to procedural efficiency.\u201d<\/p>\n<p>\n<b>About Attune Medical<sup>\u00ae <\/sup>and ensoETM<sup>\u00ae<\/sup><\/b><\/p>\n<p>\nAttune Medical\u2019s ensoETM is a single use thermal regulating device that is placed in the esophagus (similar to a standard orogastric tube) and connected to an external heat exchange unit, creating a closed-loop system for proactive controlled temperature management and reduction of the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.<\/p>\n<p>\n<i>Research mentioned in this press release was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R44HL158375. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.<\/i><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nLisa Owens, <a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#108;&#105;s&#x61;&#x6d;&#109;&#111;w&#x65;&#x6e;&#x73;&#64;gm&#x61;&#x69;&#108;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6c;&#105;s&#x61;&#x6d;&#109;o&#x77;&#x65;&#110;s&#x40;&#103;m&#x61;&#x69;&#108;&#46;&#x63;&#x6f;&#109;<\/a>, 210.601.6647<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Company\u2019s ensoETM\u00ae holds FDA marketing authorization for reducing the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Attune Medical\u00ae, a pioneer in the field of esophageal temperature management with its ensoETM\u00ae device, is providing significant support for the upcoming AF Symposium as part of the company\u2019s corporate mission. AF Symposium, scheduled &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58731","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Attune Medical\u00ae Announces Support of AF Symposium 2024 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Attune Medical\u00ae Announces Support of AF Symposium 2024 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company\u2019s ensoETM\u00ae holds FDA marketing authorization for reducing the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Attune Medical\u00ae, a pioneer in the field of esophageal temperature management with its ensoETM\u00ae device, is providing significant support for the upcoming AF Symposium as part of the company\u2019s corporate mission. AF Symposium, scheduled ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-17T15:06:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/21\/EnsoETM_inserted_illustration.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Attune Medical\u00ae Announces Support of AF Symposium 2024\",\"datePublished\":\"2024-01-17T15:06:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/\"},\"wordCount\":551,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240117068352\\\/en\\\/2000275\\\/21\\\/EnsoETM_inserted_illustration.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/\",\"name\":\"Attune Medical\u00ae Announces Support of AF Symposium 2024 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240117068352\\\/en\\\/2000275\\\/21\\\/EnsoETM_inserted_illustration.jpg\",\"datePublished\":\"2024-01-17T15:06:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240117068352\\\/en\\\/2000275\\\/21\\\/EnsoETM_inserted_illustration.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240117068352\\\/en\\\/2000275\\\/21\\\/EnsoETM_inserted_illustration.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/attune-medical-announces-support-of-af-symposium-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Attune Medical\u00ae Announces Support of AF Symposium 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Attune Medical\u00ae Announces Support of AF Symposium 2024 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/","og_locale":"en_US","og_type":"article","og_title":"Attune Medical\u00ae Announces Support of AF Symposium 2024 - Pharma Trend","og_description":"Company\u2019s ensoETM\u00ae holds FDA marketing authorization for reducing the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures. CHICAGO&#8211;(BUSINESS WIRE)&#8211;Attune Medical\u00ae, a pioneer in the field of esophageal temperature management with its ensoETM\u00ae device, is providing significant support for the upcoming AF Symposium as part of the company\u2019s corporate mission. AF Symposium, scheduled ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/","og_site_name":"Pharma Trend","article_published_time":"2024-01-17T15:06:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/21\/EnsoETM_inserted_illustration.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Attune Medical\u00ae Announces Support of AF Symposium 2024","datePublished":"2024-01-17T15:06:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/"},"wordCount":551,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/21\/EnsoETM_inserted_illustration.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/","url":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/","name":"Attune Medical\u00ae Announces Support of AF Symposium 2024 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/21\/EnsoETM_inserted_illustration.jpg","datePublished":"2024-01-17T15:06:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/21\/EnsoETM_inserted_illustration.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240117068352\/en\/2000275\/21\/EnsoETM_inserted_illustration.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/attune-medical-announces-support-of-af-symposium-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Attune Medical\u00ae Announces Support of AF Symposium 2024"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58731"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58731\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}